Cipla Limited (BOM:500087)

India flag India · Delayed Price · Currency is INR
1,485.45
-5.95 (-0.40%)
At close: Aug 8, 2025
-0.40%
Market Cap1.20T
Revenue (ttm)274.80B
Net Income (ttm)53.93B
Shares Outn/a
EPS (ttm)66.73
PE Ratio22.26
Forward PE23.70
Dividend16.00 (1.08%)
Ex-Dividend DateJun 27, 2025
Volume11,157
Average Volume70,433
Open1,486.90
Previous Close1,491.40
Day's Range1,478.10 - 1,493.80
52-Week Range1,310.05 - 1,702.00
Betan/a
RSI44.56
Earnings DateJul 28, 2025

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe... [Read more]

Industry Pharmaceutical Preparations
Founded 1935
Employees 30,313
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500087
Full Company Profile

Financial Performance

In 2024, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.

Financial Statements

News

There is no news available yet.